WithdrawnNot Applicable

An Evaluation of an Adapted STEPPS Group Within Forensic Services

Stopped: Not able to run research in the service. Research terminated.

United Kingdom0Started 2021-01-06

Plain-language summary

The purpose of this study is to determine how effective the STEPPS-HI group is at improving emotional regulation skills in those with identified difficulties in this area within forensic inpatient services. In addition, to explore whether there is increased acceptability of the adapted STEPPS group (STEPPS-HI) for this client group.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years or older. * To give informed consent to participate in the study. * Currently a resident in a low or medium secure unit. * Has been diagnosed as meeting DSM-IV criteria for a personality disorder at some stage in their mental health history. * Has identified difficulties with emotional regulation. * Be willing and have suitable abilities to participate in a group. * To be assessed by the clinical team as sufficiently psychologically robust to participate in the group and the research. Exclusion Criteria: * Psychiatric/psychological or any other difficulties that would mean that participants could not give informed consent. * Intellectual/cognitive impairment which prohibits participants ability to consent or fully comprehend the study or study materials. * Non-English speakers as there is no provision for interpreters. * Unable to manage a group environment due to risk to self and others including bullying and violence (this will be assessed by the clinical and STEPPS-HI facilitation team. * No evidence of emotional regulation difficulties.

What they're measuring

To assess change from baseline (start of group) on the Symptom Checklist-Revised (SCL-90-R), reassessing at end of group (26 weeks later).

Timeframe: Assess at baseline (start of group) and reassess end of group (26 weeks later)

To assess change from baseline (start of group) on the Zanarini Rating Scale for Borderline Personality Disorder, reassessing at end of group (26 weeks later).

Timeframe: Assess at baseline (start of group) and reassess end of group (26 weeks later)

Trial details

NCT IDNCT02601391

SponsorSussex Partnership NHS Foundation Trust

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-01-06

View on ClinicalTrials.gov More Personality Disorder trials

Plain-language summary

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

To assess change from baseline (start of group) on the Symptom Checklist-Revised (SCL-90-R), reassessing at end of group (26 weeks later).

Timeframe: Assess at baseline (start of group) and reassess end of group (26 weeks later)

To assess change from baseline (start of group) on the Zanarini Rating Scale for Borderline Personality Disorder, reassessing at end of group (26 weeks later).

Timeframe: Assess at baseline (start of group) and reassess end of group (26 weeks later)